Büdingen, Hesse, Germany
Multinationally experienced, people and result oriented. Strong analytical and conceptional skills. Enjoys new, difficult challenges. Experienced in turnaround, restructuring and change of company cultures. Strongly believes in improved results through team approach and open and direct communication. Extensive experience in marketing, sales, project management and finance. Worked in Business Development, as Management Consultant, in Regional Management and as General Manager and President for Abbott Austria and Abbott Brazil. Switch to Biotech 20 years ago as investor and CEO. Now with 30+ years experience as CEO, Business Angel and active shareholder in the growing biotech market. Lived and worked in more than 10 countries. Highly mobile. Under my leadership achieved numerous awards for fast growth and technological excellence: Deloitte Fast Forward Award (2 times), Step Award (FAZ German news paper), BMBF and Peta. Numero Uno (Excellence award of Abbott) Specialties: Health Care, Biotech, Pharma, Diagnostics, Medical Devices. Key words: General Management, Strategic Development, Turn-Around, Team Building, Marketing, Sales, Networking, medical science, gene technology, genetic testing, new intellectual property, cutting edge science, medical innovations, patient care, biosimilars, biobetters, biological drugs, reformulating, patent strategy, Pharmaceuticals, biotechnology, diagnostics, Board of Directors, board strategies, strategic planning, fundraising, venture capital, business angel investors, licensing deals, collaborative reseach agreements, partnerships, company sale.
Leading provider of e-commerce software. More than 3,000 B2C and B2B online shops value the scalability, modularity and quality of OXID eShop. This includes major companies such as Lekkerland, Fressnapf, Neckermann, Strenesse, Intersport, Gravis and Deutsche Post. They benefit from the implementation of flexible, fully customisable solutions (fast ramp up, low costs), from the know-how of over 100 certified OXID solution partners and from ongoing direct contact with the company’s professional support and development teams. OXID eShop will be further expanded by the e-commerce intelligence platform OXID eFire. OXID eFire is the gateway to cloud-based e-commerce. A single user interface provides professional management of online marketing, market places, payment services, credit checks and intelligent search. OXID eShop has been developed and published as commercial Open Source Software. This means that users benefit from fast, innovative turnaround, high quality development and dependable, long-term investment security. For further information, visit www.oxid-esales.com
M o l e c u l a r D i a g n o s t i c s : Genetic and biochemical analysis of medical samples * Build up marketing and sales development. Sales almost tenfold in 4 years. * Headcount increased form 23 to over 240 in 4 years * Canada with new branch office doubled sales in 2012. Set up longterm partnership with largest Canadian laboratory LifeLabs to develop Canadian market with lab in Toronto. * Share of sales to Big Pharma/Biotech rose from 5% to 25%. Large long-term volume contract with major Pharma player. * Developed and marketed biomarkers with Pharma companies. * US CLIA and CAP registration achieved (Dec 2012) * New accounting system introduced and processes adjusted to rapidly growing organisation * Consolidation of Austrian and German business under the Rostock laboratory, Germany. * 2 Step Awards in 2014 in the categories Finance and Markets/Customers